美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kyntra Bio Inc

7.13

-0.1700-2.33%

盘后：7.130.00000.00%16:21 EDT

成交量：3.89万

成交额：28.20万

市值：2,884.40万

市盈率：0.16

高：7.44

开：7.30

低：7.13

收：7.30

52周最高：12.60

52周最低：4.85

股本：404.54万

流通股本：362.37万

量比：0.83

换手率：1.07%

股息：- -

股息率：- -

每股收益(TTM):45.37

每股收益(LYR):45.37

净资产收益率：--

总资产收益率：-16.96%

市净率：-0.96

市盈率(LYR):0.16

数据加载中...

总览公司新闻资讯公告

Kyntra Bio公布FG-3246联合恩杂鲁胺治疗转移性去势抵抗性前列腺癌的研究者发起1B/2期研究积极数据，将于2026年ASCO GU大会展示

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/KYNB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":7.13,"timestamp":1774036800000,"preClose":7.3,"halted":0,"volume":38936,"hourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.13,"latestTime":"16:21 EDT","volume":6937,"amount":49470.162,"timestamp":1774038066643,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.023287671232876703,"floatShares":3623701,"shares":4045445,"eps":45.371456,"marketStatus":"休市中","change":-0.17,"latestTime":"03-20 16:00:00 EDT","open":7.3,"high":7.4422,"low":7.13,"amount":282006.7078,"amplitude":0.042767,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":45.371456,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.3,"preHourTrading":{"tag":"盘前","latestPrice":7.6627,"preClose":7.3,"latestTime":"08:00 EDT","volume":12,"amount":88.3254036,"timestamp":1774008017284,"change":0.3627,"changeRate":0.049685,"amplitude":0.049685},"postHourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.13,"latestTime":"16:21 EDT","volume":6937,"amount":49470.162,"timestamp":1774038066643,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8337258976560695},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","floatShares":3623701,"roa":"-16.96%","roe":"--","lyrEps":45.371456,"volumeRatio":0.8337258976560695,"shares":4045445,"dividePrice":0,"high":7.4422,"amplitude":0.042767,"preClose":7.3,"low":7.13,"week52Low":4.85,"pbRate":"-0.96","psRate":"4.48","week52High":12.6,"institutionHeld":0,"latestPrice":7.13,"eps":45.371456,"divideRate":0,"volume":38936,"delay":0,"ttmEps":45.371456,"open":7.3,"prevYearClose":8.78,"prevWeekClose":6.97,"prevMonthClose":6.93,"prevQuarterClose":8.78,"fiveDayClose":6.97,"twentyDayClose":8.32,"sixtyDayClose":8.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"KYNB","fiscalQuarterEnding":"2025/12","expectedEps":-3.89,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":-3.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYNB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYNB","date":"2026-03-20","current":0.157147,"percent":0.734694,"low":0.128311,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"high":0.18215,"avg":0.150059,"sd":0.015515,"marketCap":29541837},"quantilePoints":[{"date":"2026-01-09","current":0.17821,"twenty":0.178998,"median":0.18018,"eighty":0.181362,"marketCap":38431727},{"date":"2026-01-16","current":0.170144,"twenty":0.170369,"median":0.172958,"eighty":0.17821,"marketCap":36692186},{"date":"2026-01-23","current":0.168268,"twenty":0.168268,"median":0.171269,"eighty":0.17821,"marketCap":36287641},{"date":"2026-01-30","current":0.150259,"twenty":0.160389,"median":0.169206,"eighty":0.172958,"marketCap":32404014},{"date":"2026-02-06","current":0.140692,"twenty":0.153073,"median":0.163953,"eighty":0.171457,"marketCap":30340837},{"date":"2026-02-13","current":0.140317,"twenty":0.147445,"median":0.160201,"eighty":0.171269,"marketCap":30259928},{"date":"2026-02-20","current":0.14707,"twenty":0.146282,"median":0.158795,"eighty":0.170369,"marketCap":31716288},{"date":"2026-02-27","current":0.13075,"twenty":0.144894,"median":0.154199,"eighty":0.170144,"marketCap":28196751},{"date":"2026-03-06","current":0.129155,"twenty":0.137315,"median":0.150635,"eighty":0.168643,"marketCap":27852888},{"date":"2026-03-13","current":0.131688,"twenty":0.133714,"median":0.147445,"eighty":0.165191,"marketCap":28399023},{"date":"2026-03-20","current":0.161033,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"marketCap":29541837}],"updateTime":1774154333392},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYNB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173376495","title":"Kyntra Bio公布FG-3246联合恩杂鲁胺治疗转移性去势抵抗性前列腺癌的研究者发起1B/2期研究积极数据，将于2026年ASCO GU大会展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1173376495","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173376495?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 06:11","pubTimestamp":1771884675,"startTime":"0","endTime":"0","summary":"Kyntra Bio公司宣布，其FG-3246与恩杂鲁胺联合用药方案针对转移性去势抵抗性前列腺癌患者的临床研究取得积极进展。这项由研究者发起的1B/2期试验数据显示出显著治疗潜力，相关完整数据报告已获选将于2026年美国临床肿瘤学会泌尿生殖系统肿瘤研讨会进行正式发布。\n该研究聚焦于晚期前列腺癌治疗领域的前沿探索，通过双药联用策略旨在突破现有治疗方案瓶颈。试验结果不仅验证了联合用药的安全性特征，更展现出令人鼓舞的疗效信号，为转移性去势抵抗性前列腺癌患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}